Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (75390)	3/27/2002 3:38:39 PM
From: The Osprey	Read Replies (1) \| Respond to of 122087

shorted MHUT at 3.56...I agree.I mentioned this back in January or February if I remember correctly. The Osprey

To: Anthony@Pacific who wrote (75390)	3/27/2002 7:41:19 PM
From: Anthony@Pacific	Respond to of 122087

OOOOPS!! this cant be good for the MHUT fda.gov November 21, 2001 RECALLS AND FIELD CORRECTIONS: DRUGS CLASS III _______________________ PRODUCT Estratest Tablets (Esterified Estrogen 1.25mg and Methyltestosterone 2.5mg), Bottles of 100, NDC # 0032-1026-01, Rx only, Recall # D-034-2. CODE Lot 91666, exp. November 2002. RECALLING FIRM/ MANFACTURER Recalling Firm: Solvay Pharmaceuticals, Inc. Marietta, GA. Manufacturer: Solvay Pharmaceuticals, Inc. Baudette, MN. REASON Mis-Labeling -bottles may contain Estratest HS tablets (half strength of both active ingredients). PRODUCT 17,315 bottles. DISTRIBUTION Nationwide.